Table 2B.
Characteristics of mice in experiment B (after treatment).
| Variables | Met-/SCFA- | Met-/SCFA+ | Met+/SCFA- | Met+/SCFA+ |
|---|---|---|---|---|
| Food intake (g/d) | 4.5 ± 0.4 | 3.8 ± 0.6* | 3.9 ± 0.6* | 3.5 ± 0.6** |
| Weight (g) | 43.5 ± 3.8 | 42.0 ± 5.3 | 44.5 ± 5.7 | 40.7 ± 5.6 |
| Fasting glucose (mmol/L) | 24.2 ± 5.0 | 24.2 ± 4.5 | 17.5 ± 4.7** | 18.8 ± 5.2* |
| 2h glucose (mmol/L) | 29.3 ± 5.2 | 30.7 ± 4.0 | 20.6 ± 3.9** | 21.2 ± 5.0** |
| Acetic acid (mmol/L) | 35.9 ± 3.0 | 35.0 ± 3.1 | 36.0 ± 2.9 | 36.8 ± 3.7 |
| Propanoic acid (mmol/L) | 15.4 ± 2.0 | 19.4 ± 1.8** | 17.0 ± 1.6* | 19.1 ± 1.7** |
| Butyric acid (mmol/L) | 4.5 ± 0.7 | 4.3 ± 0.4 | 5.9 ± 0.7** | 5.3 ± 0.8* |
| Total GLP-1 (pmol/L) | 29.9 ± 5.0 | 35.3 ± 3.4* | 44.5 ± 5.9** | 49.8 ± 10.1** |
| Active GLP-1 (pmol/L) | 3.3 ± 0.6 | 3.5 ± 0.5 | 4.1 ± 0.7* | 4.9 ± 0.9** |
| PYY (pmol/L) | 13.4 ± 1.8 | 12.1 ± 1.9 | 13.2 ± 1.7 | 15.0 ± 2.5 |
*Compared with the Met-/SCFA- group, P<0.05; **Compared with the Met-/SCFA- group, P<0.01.